quotes and stock data may be delayed 15 minutes
52 wk low
52 wk hi
Burn Rate (Qtr)
mkt cap api
Click on drug name or indication to see upcoming trial info, prior data, and more general information.
No drug found
We don't have any drug data for this company yet
Drug | Disease (links)
Stage (next event)
LYR-210 (anti-inflammatory implantable drug matrix)
Rhinosinusitis, Chronic rhinosinusitis, Neurological disorder, Parkinson's disease
search in progress
Pipeline powered by
Lyra Therapeutics is a clinical-stage company developing medicines precisely designed to target ear, nose and throat (ENT) diseases. Our goal is to transform the ENT treatment paradigm by providing effective solutions for physicians and new treatment options for their patients.
See what the community is saying - click to see full post.